Healthcare -
Biotechnology - NASDAQ - US
$ 0.26
3.09 %
$ 16.8 M
Market Cap
-0.42
P/E
GLYC - CAPITAL EXPENDITURES
Capital Expenditures GLYC - GlycoMimetics, Inc.
-21.4 K
LAST VALUE
-19.65%
2 YEAR CAGR
29.81%
5 YEAR CAGR
12.58%
10 YEAR CAGR